Chemical Compound
(2R)-N-[(3S,6S,8S,12S,13R,16S,17R,20S,23S)-13-[(2S)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]-4-methyl-2-(methylamino)pentanamide
CAS Registry Number
77327-04-9
Primary record
(2R)-N-[(3S,6S,8S,12S,13R,16S,17R,20S,23S)-13-[(2S)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]-4-methyl-2-(methylamino)pentanamide
- 库存
- 6,608 克
- 纯度
- 98.2 %
- CAS
- 77327-04-9
化合物标识与属性
- CAS
- 77327-04-9
- PubChem CID
- 123844
- SMILES
- CC[C@H](C)[C@@H]1[C@H](CC(=O)O[C@H](C(=O)[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N([C@H](C(=O)O[C@@H]([C@@H](C(=O)N1)NC(=O)[C@@H](CC(C)C)NC)C)CC3=CC=C(C=C3)OC)C)CC(C)C)C)C(C)C)O
- Canonical SMILES
- CC[C@H](C)[C@H]1NC(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)[C@@H](C)OC(=O)[C@H](Cc2ccc(OC)cc2)N(C)C(=O)[C@@H]2CCCN2C(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)C(=O)[C@H](C(C)C)OC(=O)C[C@@H]1O
名称与同义词
- Didemnin A
- didemnins
- Oncoprecipitin A
- Didemnin D
- Didemnin E
- didemnin-a
- 4LSZ9C5HOB
- UNII-4LSZ9C5HOB
- AC1L3XEG
- DIDEMNIN A [MI]
- RefChem:133284
- NSC 325319
- CHEMBL499943
- NSC 351910
- SCHEMBL13413231
- XQZOGOCTPKFYKC-VSZULPIASA-N
- NSC-351910
- C49H78N6O12
- AR-1K3056
- CID123844
- C49-H78-N6-O12
- 77327-04-9
- LS-186759
- LS-187439
- Q27260029
- (3S-(1(2R*,4R*),3R*,4S*,5R*))-N-(1-(N-(4-((3-Hydroxy-5-methyl-4-((N-(N-methyl-D-leucyl)-L-threonyl)amino)-1-oxoheptyl)oxy)-2,5-dimethyl-1,3-dioxohexyl)-L-leucyl)-L-prolyl)-N,O-dimethyl-L-tyrosine phi-lactone
- (2R)-N-[(3S,6S,8S,12S,13R,16S,17R,20S,23S)-13-[(2S)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]-4-methyl-2-(methylamino)pentanamide
- L-Tyrosine, N-[1-[N-[4-[[3-hydroxy-5-methyl-4- [[N-(N-methyl
- L-Tyrosine, N-(1-(N-(4-((3-hydroxy-5-methyl-4-((N-(N-methyl-D-leucyl)-L-threonyl)amino)-1-oxoheptyl)oxy)-2,5-dimethyl-1,3-dioxohexyl)-L-leucyl)-L-prolyl)-N,O-dimethyl-, phi-lactone, (3S-((2R*,4R*),3R*,4S*,5R*))-
- 15H-Pyrrolo(2,1-f)(1,15,4,7,10,20)dioxatetraazacyclotricosine, cyclic peptide deriv
- 15H-Pyrrolo(2,1-f)(1,15,4,7,10,20)dioxatetraazacyclotricosine, cyclic peptide deriv.
- (2R)-N-((3S,6S,8R,12S,13R,16S,17R,20S,23S)-20-benzyl-12-hydroxy-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8,13-di(propan-2-yl)-9,18-dioxa-1,4,14,21-tetrazabicyclo(21.3.0)hexacosan-16-yl)-4-methyl-2-(methylamino)pentanamide
- (2R)-N-((3S,6S,8S,12S,13R,16S,17R,20S)-13-((2S)-butan-2-yl)-20-((4-methoxyphenyl)methyl)-6,12,17,21-tetramethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo(21.3.0)hexacosan-16-yl)-4-methyl-2-(methylamino)pentanamide
- (2R)-N-((3S,6S,8S,12S,13R,16S,17R,20S,23R)-13-((2S)-butan-2-yl)-12-hydroxy-20-((4-methoxyphenyl)methyl)-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo(21.3.0)hexacosan-16-yl)-4-methyl-2-(methylamino)pentanamide
- (2R)-N-((3S,6S,8S,12S,13R,16S,17R,20S,23S)-13-((2S)-butan-2-yl)-12-hydroxy-20-((4-methoxyphenyl)methyl)-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo(21.3.0)hexacosan-16-yl)-4-methyl-2-(methylamino)pentanamide
- (2R)-N-[(3S,6S,8S,12S,13R,16S,17R,20S,23S)-12-hydroxy-3-isobutyl-8-isopropyl-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-13-[(1S)-1-methylpropyl]-2,5,7,10,15,19,22-heptaoxo-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]-4-methyl-2-(methylamino)pentanamide
- (3S-(1(2R*,4R*),3R*,4S*,5R*))-N-(1-(N-(4-((3-HYDROXY-5-METHYL-4-((N-(N-METHYL-D-LEUCYL)-L-THREONYL)AMINO)-1-OXOHEPTYL)OXY)-2,5-DIMETHYL-1,3-DIOXOHEXYL)-L-LEUCYL)-L-PROLYL)-N,O-DIMETHYL-L-TYROSINE .PHI.-LACTONE
- 16136-66-6
- L-TYROSINE, N-(1-(N-(4-((3-HYDROXY-5-METHYL-4-((N-(N-METHYL-D-LEUCYL)-L-THREONYL)AMINO)-1-OXOHEPTYL)OXY)-2,5-DIMETHYL-1,3-DIOXOHEXYL)-L-LEUCYL)-L-PROLYL)-N,O-DIMETHYL-, .PHI.-LACTONE, (3S-(1(2R*,4R*),3R*,4S*,5R*))-
- L-tyrosine, N-(1-(N-(4-((3-hydroxy-5-methyl-4-((N-(N-methyl-D-leucyl)-L-threonyl)amino)-1-oxoheptyl)oxy)-2,5-dimethyl-1,3-dioxohexyl)-L-leucyl)-L-prolyl)-N,O-dimethyl-, phi-lactone, (3S-(1(2R*,4R*),3R*,4S*,5R*))-
- L-Tyrosine, N-[1-[N-[4-[[3-hydroxy-5-methyl-4- [[N-(N-methyl-D-leucyl)-L-threonyl]amino]-1-oxoheptyl]oxy]- 2,5-dimethyl-1,3-dioxohexyl]-L-leucyl]-L-prolyl]- N,O-dimethyl-, .|O.-lactone, [3S-[1(2R*,4R*),3R*,4S*,5R*]]-
- N-(12-hydroxy-20-((4-methoxyphenyl)methyl)-6,17,21-trimethyl-3,13-bis(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo(21.3.0)hexacosan-16-yl)-4-methyl-2-(methylamino)pentanamide
- N-[(12R,13S)-13-[(2R)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]-4-methyl-2-(methylamino)pentanamide
- n-[(3s,6r,7s,10r,11s,15s,17s,20s)-10-(butan-2-yl)-11-hydroxy-3-(4-methoxybenzyl)-2,6,17-trimethyl-20-(2-methylpropyl)-1,4,8,13,16,18,21-heptaoxo-15-(propan-2-yl)docosahydro-15h-pyrrolo[2,1-f][1,15,4,7,10,20]dioxatetraazacyclotricosin-7-yl]-n2-methyl-d-leucinamide